An open randomised study of the efficacy of standard radiotherapy with and without the addition of SRL 172 (Mycobacterium vaccae) in the treatment of patients with small cell lung cancer (SIRON 13)

Trial Profile

An open randomised study of the efficacy of standard radiotherapy with and without the addition of SRL 172 (Mycobacterium vaccae) in the treatment of patients with small cell lung cancer (SIRON 13)

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2008

At a glance

  • Drugs IMM-201 (Primary) ; Antineoplastics
  • Indications Small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top